Delivery of inhibitory signalling via co-crosslinking of FcεRI and FcγRIIB with engineered micro-surfaces as a new therapeutic conceptTools Alharbi, Waleed S. (2018) Delivery of inhibitory signalling via co-crosslinking of FcεRI and FcγRIIB with engineered micro-surfaces as a new therapeutic concept. PhD thesis, University of Nottingham.
AbstractMast cell and basophil mediators play a major role in the development of immunoglobulin E (IgE)-dependent allergic disorders. One of these mediators is histamine, which is released by activation of inflammatory cells through cross-linking of the high affinity IgE receptor (FcεRI). The current immunotherapies are accompanied by major drawbacks, such as an increase the risk of anaphylaxis and systemic reaction, difficulties in allergen extract standardisation of allergen-specific immunotherapy (SIT), and a small but worrying increase in the incidence of cancer with omalizumab. It is known that co-aggregation of immunoglobulin G (IgG) low-affinity receptor (FcγRIIB) with FceεRI can lead to inhibition of mast cell degranulation, thus inhibiting production of pharmacological mediators. The potential underlying this principle has been highlighted by many approaches published in the literature.
Actions (Archive Staff Only)
|